GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cartesian Therapeutics Inc (STU:1S70) » Definitions » Investments And Advances

Cartesian Therapeutics (STU:1S70) Investments And Advances : €1.84 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cartesian Therapeutics Investments And Advances?

Cartesian Therapeutics's Investments And Advances for the quarter that ended in Mar. 2024 was €1.84 Mil.

Cartesian Therapeutics's quarterly Investments And Advances declined from Sep. 2023 (€1.87 Mil) to Dec. 2023 (€1.83 Mil) but then increased from Dec. 2023 (€1.83 Mil) to Mar. 2024 (€1.84 Mil).

Cartesian Therapeutics's annual Investments And Advances increased from Dec. 2021 (€1.77 Mil) to Dec. 2022 (€1.89 Mil) but then declined from Dec. 2022 (€1.89 Mil) to Dec. 2023 (€1.83 Mil).


Cartesian Therapeutics Investments And Advances Historical Data

The historical data trend for Cartesian Therapeutics's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cartesian Therapeutics Investments And Advances Chart

Cartesian Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.77 1.89 1.83

Cartesian Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.87 1.85 1.87 1.83 1.84

Cartesian Therapeutics Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Cartesian Therapeutics (STU:1S70) Business Description

Traded in Other Exchanges
Address
65 Grove Street, Watertown, MA, USA, 02472
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. Its product pipeline includes MMA-101, SEL-212 for Chronic Severe Gout, SEL-313 for Ornithine Transcarbamylase Deficiency (OTC), and others.

Cartesian Therapeutics (STU:1S70) Headlines

No Headlines